Related Experiment Video
Updated: Oct 19, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Circular RNA WHSC1 exerts oncogenic properties by regulating miR-7/TAB2 in lung cancer
Sisi Guan1, Li Li1, Wen-Shu Chen2
1Department of Geriatrics, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Abstract:
Circular RNA is a newly discovered member of non-coding RNA (ncRNA) and regulates the target gene by acting as a micro-RNA sponge. It plays vital roles in various diseases. However, the functions of circular RNA in non-small cell lung cancer (NSCLC) remain still unclear. Our data showed that circ-WHSC1 was highly expressed in NSCLC cells and tissues. Both in vitro and in vivo experiments showed that circ-WHSC1 promoted NSCLC proliferation. circ-WHSC1 also promoted the migration and invasion of lung cancer cells. Through bioinformatic analysis and functional experiments, we showed that circ-WHSC1 could act as a sponge for micro-RNA-7 (miR-7) and regulate the expression of TAB2 (TGF-beta activated kinase one binding protein two). Inhibition of the circ-WHSC1/miR-7/TAB2 pathway could effectively attenuate lung cancer progression. In summary, this study confirmed the existence and oncogenic function of circ-WHSC1 in NSCLC. The research suggests that the circ-WHSC1/miR-7/TAB2 axis might be a potential target for NSCLC therapy.
Insights
Circular RNA circ-WHSC1 promotes non-small cell lung cancer (NSCLC) progression by regulating miR-7 and TAB2. Targeting this circ-WHSC1/miR-7/TAB2 pathway may offer a new therapeutic strategy for NSCLC.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Circular RNAs (circRNAs) are novel non-coding RNAs regulating gene expression.
- circRNAs function as micro-RNA sponges, impacting various diseases.
- The role of circRNAs in non-small cell lung cancer (NSCLC) is not fully understood.
Purpose of the Study:
- To investigate the function of circ-WHSC1 in NSCLC.
- To elucidate the molecular mechanism of circ-WHSC1 in NSCLC progression.
- To evaluate the circ-WHSC1/miR-7/TAB2 axis as a potential therapeutic target in NSCLC.
Main Methods:
- Quantitative real-time PCR to assess circ-WHSC1 expression in NSCLC tissues and cells.
- In vitro assays (proliferation, migration, invasion) and in vivo xenograft models to evaluate circ-WHSC1's functional role.
- Bioinformatic analysis, luciferase reporter assays, and Western blotting to identify and validate the interaction between circ-WHSC1, miR-7, and TAB2.
Main Results:
- circ-WHSC1 was significantly upregulated in NSCLC tissues and cells.
- circ-WHSC1 overexpression promoted NSCLC cell proliferation, migration, and invasion.
- circ-WHSC1 acted as a sponge for miR-7, thereby upregulating TAB2 expression.
- Inhibition of the circ-WHSC1/miR-7/TAB2 pathway suppressed NSCLC progression.
Conclusions:
- circ-WHSC1 exhibits oncogenic functions in NSCLC.
- The circ-WHSC1/miR-7/TAB2 signaling pathway plays a critical role in NSCLC development.
- circ-WHSC1 represents a potential diagnostic biomarker and therapeutic target for NSCLC.
Related Concept Videos
MicroRNAs
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Abnormal Proliferation
lncRNA - Long Non-coding RNAs
Experimental RNAi
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

